Andrew Spaventa insider trades
Open-market stock purchases and sales by Andrew Spaventa, Chief Executive Officer at Singular Genomics Systems, Inc, from SEC Form 4 filings since Jun 1, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- OMIC Singular Genomics Systems, Inc: 2 buys, 4 sales, last Feb 21, 2025